taurine has been researched along with Cirrhosis, Liver in 46 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten cirrhotic patients who experienced muscle cramps one or more times/week were enrolled in this prospective single-arm study and administered with an oral taurine solution (1 g/50 mL) thrice a day for 4 weeks." | 9.41 | Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study. ( Hwang, SH; Jang, ES; Jeong, SH; Kim, JW, 2021) |
| "The study employed a rat model to examine the effects of taurine (Tau) on prevention and therapy of non-alcoholic fatty liver disease (NAFLD)." | 8.02 | Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β. ( Chen, XQ; Huang, L; Lan, LC; Liang, G; Lv, ZL; Shan, QW; Tang, Q; Yang, MX; Yao, Z; Zhu, FL, 2021) |
| "We investigated whether the oral administration of SAMe influences the hepatic availability of sulphur amino acids and the extent of bile salt amidation with taurine in liver cirrhosis." | 7.69 | Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis. ( Angelico, M; Baiocchi, L; Capocaccia, L; Gandin, C; Nistri, A, 1994) |
| "We administered 3 g of taurine orally for four weeks to 35 patients suffering from liver cirrhosis with repeated muscle cramp (MC)." | 7.69 | [Painful muscle cramps in liver cirrhosis and effects of oral taurine administration]. ( Ideguchi, S; Iguchi, Y; Mitsui, Y; Ohmoto, K; Ohumi, T; Shimabara, M; Takatori, K; Yamamoto, R; Yamamoto, S, 1994) |
| "On separate occasions (24-14C)cholic acid and (24-14C)chenodeoxycholic acid were administered intravenously to patients with liver cirrhosis and the isotope excretion in urine and faeces monitored." | 7.68 | Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids. ( Hedenborg, G; Jönsson, G; Norman, A; Wisén, O, 1991) |
| "Taurine (TAU) is an abundant amino acid with substantial anti-inflammatory and antioxidative properties." | 5.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
| "Taurine has various physiological functions and hepatoprotective properties as well as anti-inflammatory and immunomodulatory activity." | 5.43 | Taurine drinking ameliorates hepatic granuloma and fibrosis in mice infected with Schistosoma japonicum. ( Huang, J; Ni, XQ; Qi, YF; Yu, YR; Zhu, YH, 2016) |
| "Ten cirrhotic patients who experienced muscle cramps one or more times/week were enrolled in this prospective single-arm study and administered with an oral taurine solution (1 g/50 mL) thrice a day for 4 weeks." | 5.41 | Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study. ( Hwang, SH; Jang, ES; Jeong, SH; Kim, JW, 2021) |
| "Taurine was found to decrease TAA-induced hepatic lipid peroxidation and to increase TAA-depleted vitamin E levels and GSH-Px activities." | 5.31 | Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. ( Aykaç-Toker, G; Balkan, J; Cevikbaş, U; Doğru-Abbasoğlu, S; Kanbağli, O; Uysal, M, 2001) |
| "Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 5.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
| "Thirty patients were screened and 22 included in the efficacy analysis (12 taurine/10 placebo; 64% male, mean age: 52 ± 11 years, Child A: 9%, B:64%, C:27%, ascites:68%)." | 5.27 | Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension. ( Ferlitsch, A; Ferlitsch, M; Gerner, C; Heinisch, B; Kivaranovic, D; Mandorfer, M; Paternostro, R; Peck-Radosavljevic, M; Reiberger, T; Schwarzer, R; Trauner, M; Wolrab, D, 2018) |
| "The study employed a rat model to examine the effects of taurine (Tau) on prevention and therapy of non-alcoholic fatty liver disease (NAFLD)." | 4.02 | Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β. ( Chen, XQ; Huang, L; Lan, LC; Liang, G; Lv, ZL; Shan, QW; Tang, Q; Yang, MX; Yao, Z; Zhu, FL, 2021) |
| "We have previously reported that oral taurine administration reduced the frequency of painful muscle cramps in patients with liver cirrhosis, and that skeletal muscle taurine concentration was significantly decreased after exercise." | 3.72 | The harmful effect of exercise on reducing taurine concentration in the tissues of rats treated with CCl4 administration. ( Bouscarel, B; Doy, M; Ikegami, T; Matsuzaki, Y; Miyakawa, S; Miyazaki, T; Tanaka, N, 2004) |
| "We investigated whether the oral administration of SAMe influences the hepatic availability of sulphur amino acids and the extent of bile salt amidation with taurine in liver cirrhosis." | 3.69 | Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis. ( Angelico, M; Baiocchi, L; Capocaccia, L; Gandin, C; Nistri, A, 1994) |
| "We administered 3 g of taurine orally for four weeks to 35 patients suffering from liver cirrhosis with repeated muscle cramp (MC)." | 3.69 | [Painful muscle cramps in liver cirrhosis and effects of oral taurine administration]. ( Ideguchi, S; Iguchi, Y; Mitsui, Y; Ohmoto, K; Ohumi, T; Shimabara, M; Takatori, K; Yamamoto, R; Yamamoto, S, 1994) |
| "On separate occasions (24-14C)cholic acid and (24-14C)chenodeoxycholic acid were administered intravenously to patients with liver cirrhosis and the isotope excretion in urine and faeces monitored." | 3.68 | Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids. ( Hedenborg, G; Jönsson, G; Norman, A; Wisén, O, 1991) |
| "Taurine (TAU) is an abundant amino acid with substantial anti-inflammatory and antioxidative properties." | 1.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
| "Unfortunately, a standard treatment for liver fibrosis has not been approved yet due to its complicated pathogenesis." | 1.62 | Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway. ( Elmorsy, MA; Ghanim, AMH; Metwaly, HA; Younis, NS, 2021) |
| "The treatment of alcohol dependence (AD) is a complex activity as the variables are numerous; however, those which must necessarily be taken into account are the type of AD, the internal comorbidities and the presence of any psychiatric comorbidity." | 1.43 | Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy. ( Borro, P; Leone, S; Testino, G, 2016) |
| "Taurine has various physiological functions and hepatoprotective properties as well as anti-inflammatory and immunomodulatory activity." | 1.43 | Taurine drinking ameliorates hepatic granuloma and fibrosis in mice infected with Schistosoma japonicum. ( Huang, J; Ni, XQ; Qi, YF; Yu, YR; Zhu, YH, 2016) |
| "Taurine deficiency has been suggested to contribute to the pathogenesis and complications of advanced hepatic diseases." | 1.40 | Branched-chain amino acids inhibit the TGF-beta-induced down-regulation of taurine biosynthetic enzyme cysteine dioxygenase in HepG2 cells. ( Fujitani, S; Hagiwara, A; Ishizaki, S; Satsu, H; Shimizu, M; Sonaka, I; Takehana, K, 2014) |
| "Non-alcoholic fatty liver disease (NAFLD) is the commonest form of chronic liver disease in developed countries." | 1.40 | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. ( Azuma, T; Hoshi, N; Kawano, Y; Minami, A; Nishiumi, S; Terashima, Y; Yoshida, M, 2014) |
| "Taurine treatment reduced fibrosis scores significantly as compared to placebo." | 1.35 | Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury. ( Comert, B; Mas, MR; Mas, N; Tasci, I; Tuncer, M, 2008) |
| "A continuation of liver fibrosis after undergoing successful Kasai operation has become the important clinical issue in the long-term follow-up of patients with biliary atresia (BA)." | 1.32 | Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study. ( Iinuma, Y; Kanada, S; Kinoshita, Y; Kubota, M; Yagi, M; Yamazaki, S, 2003) |
| "Taurine was found to decrease TAA-induced hepatic lipid peroxidation and to increase TAA-depleted vitamin E levels and GSH-Px activities." | 1.31 | Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. ( Aykaç-Toker, G; Balkan, J; Cevikbaş, U; Doğru-Abbasoğlu, S; Kanbağli, O; Uysal, M, 2001) |
| "Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 1.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (23.91) | 18.7374 |
| 1990's | 10 (21.74) | 18.2507 |
| 2000's | 6 (13.04) | 29.6817 |
| 2010's | 14 (30.43) | 24.3611 |
| 2020's | 5 (10.87) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, Z | 1 |
| Liang, G | 1 |
| Lv, ZL | 1 |
| Lan, LC | 1 |
| Zhu, FL | 1 |
| Tang, Q | 1 |
| Huang, L | 1 |
| Chen, XQ | 1 |
| Yang, MX | 1 |
| Shan, QW | 1 |
| Ommati, MM | 1 |
| Mobasheri, A | 1 |
| Ma, Y | 1 |
| Xu, D | 1 |
| Tang, Z | 1 |
| Manthari, RK | 1 |
| Abdoli, N | 1 |
| Azarpira, N | 1 |
| Lu, Y | 1 |
| Sadeghian, I | 1 |
| Mousavifaraz, A | 1 |
| Nadgaran, A | 1 |
| Nikoozadeh, A | 1 |
| Mazloomi, S | 1 |
| Mehrabani, PS | 1 |
| Rezaei, M | 1 |
| Xin, H | 1 |
| Mingyu, Y | 1 |
| Niknahad, H | 1 |
| Heidari, R | 1 |
| Chen, F | 1 |
| Yao, Y | 1 |
| Li, Z | 1 |
| Deng, L | 1 |
| He, R | 1 |
| Jang, ES | 1 |
| Hwang, SH | 1 |
| Kim, JW | 1 |
| Jeong, SH | 1 |
| Younis, NS | 1 |
| Ghanim, AMH | 1 |
| Elmorsy, MA | 1 |
| Metwaly, HA | 1 |
| Schwarzer, R | 1 |
| Kivaranovic, D | 1 |
| Mandorfer, M | 1 |
| Paternostro, R | 1 |
| Wolrab, D | 1 |
| Heinisch, B | 1 |
| Reiberger, T | 1 |
| Ferlitsch, M | 1 |
| Gerner, C | 1 |
| Trauner, M | 1 |
| Peck-Radosavljevic, M | 1 |
| Ferlitsch, A | 1 |
| Srinivas, NR | 1 |
| Liang, XQ | 1 |
| Liang, J | 2 |
| Zhao, XF | 1 |
| Wang, XY | 1 |
| Deng, X | 1 |
| Atluri, DK | 1 |
| Veluru, C | 1 |
| Mullen, K | 1 |
| Li, Y | 2 |
| Luo, Y | 1 |
| Zhang, X | 2 |
| Lin, X | 2 |
| He, M | 2 |
| Liao, M | 3 |
| Hagiwara, A | 1 |
| Ishizaki, S | 1 |
| Takehana, K | 1 |
| Fujitani, S | 1 |
| Sonaka, I | 1 |
| Satsu, H | 1 |
| Shimizu, M | 1 |
| Terashima, Y | 1 |
| Nishiumi, S | 1 |
| Minami, A | 1 |
| Kawano, Y | 1 |
| Hoshi, N | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
| Vidot, H | 1 |
| Carey, S | 1 |
| Allman-Farinelli, M | 1 |
| Shackel, N | 1 |
| Borro, P | 1 |
| Leone, S | 1 |
| Testino, G | 1 |
| Abdel-Moneim, AM | 1 |
| Al-Kahtani, MA | 1 |
| El-Kersh, MA | 1 |
| Al-Omair, MA | 1 |
| Yu, YR | 1 |
| Ni, XQ | 1 |
| Huang, J | 1 |
| Zhu, YH | 1 |
| Qi, YF | 1 |
| Cao, W | 1 |
| Li, M | 1 |
| Tasci, I | 1 |
| Mas, N | 1 |
| Mas, MR | 1 |
| Tuncer, M | 1 |
| Comert, B | 1 |
| Devi, SL | 1 |
| Viswanathan, P | 1 |
| Anuradha, CV | 1 |
| Zhuo, L | 1 |
| Zheng, L | 1 |
| Huang, Q | 1 |
| Wei, L | 1 |
| Huang, R | 1 |
| Zhang, S | 1 |
| KNAUFF, HG | 2 |
| SEYBOLD, D | 2 |
| MILLER, B | 1 |
| Iinuma, Y | 1 |
| Kubota, M | 1 |
| Yagi, M | 1 |
| Kanada, S | 1 |
| Yamazaki, S | 1 |
| Kinoshita, Y | 1 |
| Miyazaki, T | 1 |
| Matsuzaki, Y | 2 |
| Ikegami, T | 1 |
| Miyakawa, S | 1 |
| Doy, M | 1 |
| Tanaka, N | 2 |
| Bouscarel, B | 1 |
| Zhang, XL | 1 |
| Yang, GY | 1 |
| Pang, YS | 1 |
| Yuan, HF | 1 |
| Liang, JS | 1 |
| Huang, RB | 1 |
| Linnet, K | 2 |
| Andersen, JR | 1 |
| Kelbaek, H | 1 |
| Angelico, M | 2 |
| Gandin, C | 1 |
| Nistri, A | 1 |
| Baiocchi, L | 1 |
| Capocaccia, L | 1 |
| Rödenbeck, D | 1 |
| Byrd, DJ | 1 |
| Brodehl, J | 1 |
| Yamamoto, S | 3 |
| Ohmoto, K | 1 |
| Ideguchi, S | 1 |
| Yamamoto, R | 1 |
| Mitsui, Y | 1 |
| Shimabara, M | 1 |
| Iguchi, Y | 1 |
| Ohumi, T | 1 |
| Takatori, K | 1 |
| Gentile, S | 1 |
| Bologna, E | 1 |
| Terracina, D | 1 |
| Osuga, T | 1 |
| Bianchi, G | 2 |
| Bugianesi, E | 1 |
| Ronchi, M | 2 |
| Fabbri, A | 1 |
| Zoli, M | 1 |
| Marchesini, G | 2 |
| Brizi, M | 1 |
| Rossi, B | 1 |
| Grossi, G | 1 |
| Balkan, J | 1 |
| Doğru-Abbasoğlu, S | 1 |
| Kanbağli, O | 1 |
| Cevikbaş, U | 1 |
| Aykaç-Toker, G | 1 |
| Uysal, M | 1 |
| Hanson, RF | 1 |
| Williams, GC | 1 |
| Hachey, D | 1 |
| Sharp, HL | 1 |
| Danielsson, H | 1 |
| Sjövall, J | 1 |
| Potgieter, AS | 1 |
| Opsomer, L | 1 |
| Hedenborg, G | 1 |
| Jönsson, G | 1 |
| Wisén, O | 1 |
| Norman, A | 1 |
| Sherr, HP | 1 |
| Nair, PP | 1 |
| White, JJ | 1 |
| Banwell, JG | 1 |
| Lockwood, DH | 1 |
| Bousquet, B | 1 |
| Larregue, M | 1 |
| Barthélémy, JP | 1 |
| Dreux, C | 1 |
| Civatte, J | 1 |
| Szantay, I | 1 |
| Szirmai, E | 1 |
| Cotul, S | 1 |
| Neale, G | 1 |
| Lewis, B | 1 |
| Weaver, V | 1 |
| Panveliwalla, D | 1 |
| Kroll, J | 1 |
| Lund, E | 1 |
| Hamelmann, H | 1 |
| Kanters, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis[NCT05724485] | Phase 4 | 50 participants (Anticipated) | Interventional | 2023-04-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for taurine and Cirrhosis, Liver
| Article | Year |
|---|---|
Systematic review: the treatment of muscle cramps in patients with cirrhosis.
Topics: Albumins; Amino Acids, Branched-Chain; Carnitine; Humans; Liver Cirrhosis; Muscle Cramp; Propiopheno | 2014 |
Bile acid metabolism.
Topics: Animals; Bile Acids and Salts; Cholelithiasis; Cholestasis; Cholesterol; Diet; Glycine; Hormones; Hy | 1975 |
3 trials available for taurine and Cirrhosis, Liver
| Article | Year |
|---|---|
Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study.
Topics: Administration, Oral; Adult; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Pilot | 2021 |
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Ascites; Double-Blind Method; Female; Hemodynamics; Humans | 2018 |
Plasma taurine in liver cirrhosis with painful muscle cramps.
Topics: Administration, Oral; Humans; Liver Cirrhosis; Muscle Cramp; Pain; Reference Values; Taurine | 1996 |
41 other studies available for taurine and Cirrhosis, Liver
| Article | Year |
|---|---|
Taurine Reduces Liver Damage in Non-Alcoholic Fatty Liver Disease Model in Rats by Down-Regulating IL-9 and Tumor Growth Factor TGF-β.
Topics: Animals; Disease Models, Animal; Down-Regulation; Interleukin-9; Intestinal Mucosa; Liver; Liver Cir | 2021 |
Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.
Topics: Animals; Antioxidants; Bile Ducts; Cholestasis; Fibrosis; Inflammation; Ligation; Liver; Liver Cirrh | 2022 |
Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients.
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Female; Glycine; Hepatitis B virus; Hepatitis B, Chro | 2023 |
Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway.
Topics: Actins; Animals; Antioxidants; Caspase 3; Gene Expression Regulation; Humans; Liver Cirrhosis; Lymph | 2021 |
Letter: high oral dose of taurine for portal hypertension in cirrhotic patients-some clinical pharmacology considerations.
Topics: Humans; Hypertension, Portal; Liver Cirrhosis; Pharmacology, Clinical; Taurine | 2018 |
Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells.
Topics: Cell Line; Gene Expression Profiling; Gene Regulatory Networks; Hepatic Stellate Cells; Humans; Live | 2019 |
An alternative treatment for muscle cramps in patients with liver cirrhosis.
Topics: Female; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Taurine; Treatment Outcome | 2013 |
Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors.
Topics: Animals; Catechin; Cell Line; Cell Proliferation; Collagen Type I; Down-Regulation; Drug Therapy, Co | 2013 |
Branched-chain amino acids inhibit the TGF-beta-induced down-regulation of taurine biosynthetic enzyme cysteine dioxygenase in HepG2 cells.
Topics: Amino Acids, Branched-Chain; Animals; Cysteine Dioxygenase; Down-Regulation; Hep G2 Cells; Humans; L | 2014 |
Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis.
Topics: Animals; Choline; Diet; Fatty Liver; Liver; Liver Cirrhosis; Male; Metabolome; Methionine; Mice, Inb | 2014 |
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug C | 2016 |
Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbon Tetrachloride; Cytokines; Free R | 2015 |
Taurine drinking ameliorates hepatic granuloma and fibrosis in mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Cercaria; Chemokines; Cytokines; Drinking Water; Granuloma; Humans; L | 2016 |
Txn1, Ctsd and Cdk4 are key proteins of combination therapy with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats.
Topics: Animals; Anticarcinogenic Agents; Carbon Tetrachloride Poisoning; Catechin; Cathepsin D; Cyclin-Depe | 2017 |
Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury.
Topics: Animals; Carbon Tetrachloride; Cell Nucleus; Disease Models, Animal; Endoplasmic Reticulum; Hepatocy | 2008 |
Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation.
Topics: Amino Acids; Animals; Antioxidants; Central Nervous System Depressants; Collagen; Cytokines; Ethanol | 2010 |
Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats.
Topics: Actins; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferas | 2012 |
[FREE PLASMA AMINO ACIDS IN LIVER CIRRHOSIS AND HEPATITIS].
Topics: Alanine; Amino Acids; Blood; Chromatography; Glutamine; Glycine; Hepatitis; Humans; Ion Exchange Res | 1964 |
Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biliary Atresia; Child; Child, Presch | 2003 |
The harmful effect of exercise on reducing taurine concentration in the tissues of rats treated with CCl4 administration.
Topics: Animals; Brain Chemistry; Carbon Tetrachloride; Liver; Liver Cirrhosis; Male; Muscle, Skeletal; Oxid | 2004 |
[Observation of the promotion effect taurine on hepatic stellate cell's apoptosis in rat hepatic fibrosis model].
Topics: Animals; Apoptosis; Carbon Tetrachloride Poisoning; Hepatocytes; Liver; Liver Cirrhosis; Male; Rando | 2005 |
Differential diagnostic value in hepatobiliary disease of serum conjugated bile acid concentrations and some routine liver tests assessed by discriminant analysis.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bi | 1983 |
The patterns of glycine and taurine conjugates of bile acids in serum in hepatobiliary disease.
Topics: Adult; Aged; Bile Acids and Salts; Cholestasis, Extrahepatic; Chromatography, High Pressure Liquid; | 1982 |
Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis.
Topics: Administration, Oral; Aged; Amino Acids; Bile; Bile Acids and Salts; Female; Humans; Liver Cirrhosis | 1994 |
The plasma concentration and renal handling of taurine in healthy children and in pediatric patients with disturbed sulfur metabolism.
Topics: Adolescent; Child; Child, Preschool; Cystinosis; Cystinuria; Homocystinuria; Humans; Infant; Infant, | 1994 |
[Painful muscle cramps in liver cirrhosis and effects of oral taurine administration].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Humans; Liver Cirrhosis; Male; Middle | 1994 |
Oral taurine therapy for painful muscle cramp in liver cirrhosis.
Topics: Female; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Taurine | 1994 |
Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Blood Pressure; | 1994 |
Is taurine effective for treatment of painful muscle cramps in liver cirrhosis?
Topics: Female; Humans; Liver Cirrhosis; Middle Aged; Muscle Cramp; Taurine | 1993 |
Glutathione kinetics in normal man and in patients with liver cirrhosis.
Topics: Adult; Aged; Antidotes; Cysteine; Erythrocytes; Female; Glutathione; Glutathione Disulfide; Half-Lif | 1997 |
Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis.
Topics: Aged; Case-Control Studies; Cysteine; Cystine; Erythrocytes; Female; Glutathione; Humans; Kinetics; | 2000 |
Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress.
Topics: Administration, Oral; Animals; Carcinogens; Glutathione; Liver; Liver Cirrhosis; Male; Malondialdehy | 2001 |
Hepatic lesions and hemolysis following administration of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oyl taurine to rats.
Topics: Anemia, Hemolytic; Animals; Bile; Bile Acids and Salts; Cholic Acids; Endoplasmic Reticulum; Female; | 1977 |
Acamprosate as cause of erythema multiforme contested.
Topics: Acamprosate; Alcoholism; Erythema Multiforme; Female; Herpes Genitalis; Humans; Liver Cirrhosis; Tau | 1992 |
Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
Topics: Bile Acids and Salts; Biological Transport; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholic Acid | 1991 |
Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
Topics: Adult; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; | 1974 |
[Pellagroid syndrome with vitamin B6 deficiency. Biological and clinical study of a case].
Topics: Amino Acids; Cystine; Humans; Indoleacetic Acids; Liver Cirrhosis; Male; Metabolism, Inborn Errors; | 1972 |
[Metabolism of S35 methionine in liver cirrhosis].
Topics: Hepatitis; Humans; Hydrocortisone; Liver Cirrhosis; Methionine; Sulfur Isotopes; Taurine | 1971 |
Serum bile acids in liver disease.
Topics: Adult; Aged; Bile Acids and Salts; Biliary Tract Diseases; Cholanes; Cholestasis; Colitis, Ulcerativ | 1971 |
The effect of taurine on serum levels of aminotransferase activity in patients with cirrhosis.
Topics: Aged; Humans; Liver Cirrhosis; Taurine; Transaminases | 1966 |
[The effect of a portacaval anastomosis in liver cirrhosis on free plasma amino acids and blood ammonia after oral administration of protein].
Topics: Amino Acids; Ammonia; Dietary Proteins; Humans; Liver Cirrhosis; Portacaval Shunt, Surgical; Taurine | 1966 |